/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-06-04 05:00:012025-06-16 07:37:55Candel Therapeutics Announces Data from Phase 1 Trial of CAN-3110 in Recurrent High-Grade Glioma at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-04-13 05:04:502025-06-16 07:35:07Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D.
/wp-content/uploads/candel_logo.svg00Vince Rose/wp-content/uploads/candel_logo.svgVince Rose2020-01-08 08:00:542021-07-16 10:25:40Candel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise
